About Carabel
Recovery deserves company.
Carabel surrounds every patient with a whole dedicated care team, powered by AI, for the weeks after their acute care.
Leaving the hospital is not the end of the danger. Clinicians and researchers refer to the weeks that follow as post‑hospital syndrome: a stretch of acquired, transient vulnerability when patients are weakened by the hospitalization itself, sleep‑deprived, deconditioned, and juggling new medications. It is when people are most likely to land back in a hospital bed, and nearly one in five Medicare patients does within thirty days, often for a problem different from the one that put them there the first time.
The frustrating part is that we know what helps — because our founding team has spent decades on exactly this problem: naming post‑hospital syndrome, testing what protects patients through it, and showing that one thing makes the difference: a multidisciplinary care team that follows the patient home, catches trouble early, solves problems and overcomes challenges, and supports recovery day by day. Giving every patient a team like that has never been sustainable. Until now.
We started Carabel because we believe the weeks after discharge should be the most supported part of care, not the least. Carabel gives every patient that extraordinarily high level of care, any hour they need it, and helps make sure they are on track to their best possible recovery.
Who we are
Harlan Krumholz MD, SM
Founder · Clinical
Harlan is a cardiologist and outcomes scientist at Yale, where he founded and leads the Center for Outcomes Research and Evaluation and is Editor‑in‑Chief of JACC. One of the world's most‑cited medical researchers, he coined the term “post‑hospital syndrome” in the New England Journal of Medicine. His work has always been about helping people stay well and get well — and improving the care that supports them. Carabel focuses that mission on the weeks after the hospital, where outcomes are so often decided.
Jackson Wilkinson
Founder · Product & Tech
Time and again, Jackson has taken the most advanced technology and focused it toward its greatest impact. At PathAI, he helped unleash one of medicine's most advanced tools, changing how disease is diagnosed. He co‑founded Kinsights, a trusted community for parents of children with rare and complex diseases. As CTO of Project Beacon, he built one of the country's most‑loved COVID testing services. Earlier, he shaped products used by millions, including at LinkedIn. Now he's doing it again – this time to change how we care for people.
Working on post-discharge care?
If your patients go home to recover, we would love to compare notes.